Some promising news in the fight against tuberculosis came Tuesday from India, where results from trials of a new TB vaccine, the first in nearly 100 years, were presented at the 50th Union World Conference on Lung Health. The vaccine, developed by British pharmaceutical company GlaxoSmithKline (GSK) and known as…
Donors at the Global Fund’s Sixth Replenishment Conference pledged US$14 billion for the next three years to continue the fight to end HIV/AIDS, tuberculosis and malaria by 2030. The conference hosted by President Emmanuel Macron of France appealed to governments and individual donors to ensure the necessary funding to combat…
Latent tuberculosis is present in a quarter of the global population, and 10 percent of infected people will develop active TB, but new studies from the Research-Institute of the McGill University Health Centre (RI-MUHC) show that shorter course of treatment timelines with a different drug are safer and more effective…
The world is running out of options when it comes to antibiotics and the growing threat of antimicrobial resistance, the World Health Organization said in a new report released Wednesday in Geneva. There just aren’t enough promising new antibiotics in the pipeline that will beat hard-to-treat infections, including drug-resistant tuberculosis…
Tuberculosis maintained its rank as the leading cause of death in South Africa in 2015, even as the number of deaths attributable to noncommunicable diseases – notably, diabetes – continued to rise. That’s according to the just-released statistical report issued by the government’s Statistics South Africa agency. Tuberculosis was the…
By Owen Nyaka Tuberculosis (TB) accounted for 400,000 of the AIDS-related deaths worldwide in 2015, and is one of the most common causes of death in people living with HIV. The dual epidemics of TB and HIV are particularly pervasive in Africa, where HIV has been the most important contributing…